ArticleCureus2024

Renal-Limited Thrombotic Microangiopathy in a Patient Who Received Gemcitabine, Ramucirumab, and Pembrolizumab: A Case Report and Literature Review.

Sumit S Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.